This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | Switzerland |
| Facebook page | medicinesformalaria |
| Website | https://www.mmv.org/ |
| Donate page | https://www.mmv.org/partnering/our-donors/donate-mmv |
| Donors list page | https://www.mmv.org/partnering/our-donors |
| Twitter username | MedsforMalaria |
| Wikipedia page | https://en.wikipedia.org/wiki/Medicines_for_Malaria_Venture |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 16 | 4,616,720 | 22,140,316 | 10,000 | 40,000 | 1,000,500 | 1,620,000 | 2,506,839 | 4,616,720 | 9,000,000 | 10,000,000 | 10,000,000 | 115,000,000 | 160,000,000 |
| Global health | 14 | 2,506,839 | 24,231,790 | 10,000 | 40,000 | 372,520 | 1,620,000 | 1,620,000 | 2,506,839 | 9,000,000 | 9,175,319 | 24,283,163 | 115,000,000 | 160,000,000 |
| FIXME | 2 | 5,000,000 | 7,500,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Donor | Total | 2017 | 2016 | 2014 | 2013 | 2011 | 2010 | 2009 | 2007 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 339,245,061.00 | 1,000,500.00 | 4,126,839.00 | 35,078,482.00 | 164,989,240.00 | 9,010,000.00 | 10,000,000.00 | 115,000,000.00 | 40,000.00 | 0.00 |
| Wellcome Trust (filter this donee) | 15,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,000,000.00 | 0.00 | 0.00 | 0.00 | 10,000,000.00 |
| Total | 354,245,061.00 | 1,000,500.00 | 4,126,839.00 | 35,078,482.00 | 164,989,240.00 | 14,010,000.00 | 10,000,000.00 | 115,000,000.00 | 40,000.00 | 10,000,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 16) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 1,000,500.00 | 13 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to increase post-approval knowledge about the safety and appropriate use of pyronaridine-artesunate in broader patient populations beyond those evaluated in the drug’s clinical development program; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,620,000.00 | 11 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,506,839.00 | 10 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to increase post-approval knowledge about the safety and appropriate use of pyronaridine-artesunate in broader patient populations beyond those evaluated in the drug’s clinical development program; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 24,283,163.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia. | |
| Bill and Melinda Gates Foundation | 9,175,319.00 | 6 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to enable the evaluation of new antimalarial medicines with a focus on novel and easy-to-administer combination treatments that will support the elimination and eventual eradication of malaria..; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,620,000.00 | 11 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 372,520.00 | 14 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia. | |
| Bill and Melinda Gates Foundation | 160,000,000.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia. | |
| Bill and Melinda Gates Foundation | 4,616,720.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to create an open-source compound collection of 400 molecules as a resource to jump-start drug discovery efforts across a wide range of pathogens; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 9,000,000.00 | 7 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 10,000.00 | 16 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Ian Bathurst Sponsorship Programme at MMV. Investment start date: 8/15/2011 to end date: 12/30/2011. Grantee name: Medicines for Malaria Venture; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara. | |
| Wellcome Trust | 5,000,000.00 | 8 | FIXME | https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx | -- | New medicines against malaria: demonstrating activity in man. Affected regions: International; affected countries: Switzerland. | |
| Bill and Melinda Gates Foundation | 10,000,000.00 | 4 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 115,000,000.00 | 2 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 40,000.00 | 15 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. for general operating support. Investment start date: 8/17/2007 to end date: 9/17/2007. Grantee name: Medicines for Malaria Venture; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Wellcome Trust | 10,000,000.00 | 4 | FIXME | https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx | -- | Medicines for Malaria Venture. Affected regions: International; affected countries: Switzerland. |